Global Blood Plasma Products Market Research Report 2023:
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Blood Plasma Products" report has been added to ResearchAndMarkets.com's offering. ...
Source: globenewswire.com
Page 2 - Csl Behring News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Csl Behring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Csl Behring Today - Breaking & Trending Today
CSL Receives Positive CHMP Opinion for Etranacogene Dezaparvovec Gene Therapy for Adults with Hemophilia B
MARBURG, GERMANY Regulatory milestone moves CSL one step closer to bringing the promise of gene therapy for hemophilia B to patients in Europe.
Source: pressreleasepoint.com
CSL Announces Next CEO & Managing Director | PressReleasePoint
MELBOURNE, AUSTRALIA The Board of Directors of CSL Limited today announces that it has appointed Dr. Paul McKenzie as Chief Executive Officer (CEO) and Managing Director of CSL from 6 March 2023.
Source: pressreleasepoint.com
Worldwide Immunoglobulin Industry to 2028 - Prevalence of Immunodeficiency Diseases and Autoimmune D
DUBLIN--(BUSINESS WIRE)--The "Global Immunoglobulin Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.This report suggests that the global immunoglobulin market would exhibit an uptrend trend at a CAGR of 6.77% over the forecast period of 2022-2028.The market's growth is supported by drivi...
Source: pharmiweb.com
World's most expensive drug approved to treat haemophilia at R60m a dose
US regulators approved CSL Behring’s haemophilia B gene therapy, a one-off infusion that frees patients from regular treatments but costs $3.5m a dose, making it the most expensive medicine in the world.
Source: timeslive.co.za